Cargando…
Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2
Autores principales: | Willis, M. D., Robertson, N. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163169/ https://www.ncbi.nlm.nih.gov/pubmed/32303837 http://dx.doi.org/10.1007/s00415-020-09822-3 |
Ejemplares similares
-
Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies
por: Allman, M., et al.
Publicado: (2022) -
Neurology and vaccinations: considerations in the context of COVID-19/SARS-COV-2
por: Cauchi, M., et al.
Publicado: (2021) -
Multiple sclerosis: early indicators of disease and assessing future risk
por: Willis, M. D., et al.
Publicado: (2020) -
Uncovering SARS-CoV-2 kidney tropism
por: Musah, Samira
Publicado: (2021) -
Stem cell treatment for multiple sclerosis
por: Owen Pickrell, W., et al.
Publicado: (2016)